Evidence map›Paper›PMID 25344147›Full record

ArticleMolecular imaging and biology2015

Imaging caspase-3 activation as a marker of apoptosis-targeted treatment response in cancer.

Delphine L Chen, Jacquelyn T Engle, Elizabeth A Griffin, J Philip Miller, Wenhua Chu, Dong Zhou, Robert H Mach

Open access · greenAbstract read
In one paragraph

Article in Molecular imaging and biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Augmentation of [EJNMMI research · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Molecular Imaging of Apoptosis: The Case of Caspase-3 Radiotracers.International journal of molecular sciences · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Development of [Cancers · 2020
    Review
  18. Tepary Bean (Molecules (Basel, Switzerland) · 2020
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Delphine L ChenDivision of Radiological Sciences and Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University School of Medicine, Campus Box 8225, 510 S. Kingshighway Blvd., St. Louis, MO, 63110, USA, chend@mir.wustl.edu.
Jacquelyn T Engle
Elizabeth A Griffin
J Philip Miller
Wenhua Chu
Dong Zhou
Robert H Mach
Mallinckrodt (United States) · USWashington University in St. Louis · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Radiolabeled Probes for Imaging Caspase 3 ActivationR21CA121952 · NCI · WASHINGTON UNIVERSITY · PI MACH, ROBERT H · 2005 to 2008
$1.2M
Apoptosis and Inflammation ImagingK08EB006702 · NIBIB · WASHINGTON UNIVERSITY · PI CHEN, DELPHINE L · 2006 to 2010
$834k
NCI NIH HHS P30 CA091842NCI NIH HHS R21 CA121952NCI NIH HHS R33 CA121952NIBIB NIH HHS K08 EB006702
6 · The paper itself

Abstract

purposeWe tested whether positron emission tomography (PET) with the caspase-3-targeted isatin analog [(18)F]WC-4-116 could image caspase-3 activation in response to an apoptosis-inducing anticancer therapy. PROCEDURES: [(18)F]WC-4-116 uptake was determined in etoposide-treated EL4 cells. Biodistribution studies with [(18)F]WC-4-116 and [(18)F]ICMT-18, a non-caspase-3-targeted tracer, as well as [(18)F]WC-4-116 microPET imaging assessed responses in Colo205 tumor-bearing mice treated with death receptor 5 (DR5)-targeted agonist antibodies. Immunohistochemical staining and enzyme assays confirmed caspase-3 activation. Two-way analysis of variance or Student's t test assessed for treatment-related changes in tracer uptake.

results[(18)F]WC-4-116 increased 8 ± 2 fold in etoposide-treated cells. The [(18)F]WC-4-116 % ID/g also increased significantly in tumors with high caspase-3 enzyme activity (p < 0.05). [(18)F]ICMT-18 tumor uptake did not differ in tumors with high or low caspase-3 enzyme activity.

conclusions[(18)F]WC-4-116 uptake in vivo reflects increased caspase-3 activation and may be useful for detecting caspase-3-mediated apoptosis treatment responses in cancer.

Indexed as

ApoptosisAnimalsAntineoplastic AgentsCaspase 3Caspase 7Cell Line, TumorFemaleFluorine RadioisotopesHeLa CellsHumansImmunohistochemistryInhibitory Concentration 50IsatinMiceMice, Inbred BALB CMice, NudeAntineoplastic AgentsCaspase 3Caspase 7Fluorine RadioisotopesIsatinRadiopharmaceuticalsReceptors, TNF-Related Apoptosis-Inducing LigandSulfonamidesWC-4-116

Identifiers

PMID25344147
PMCPMC4874215
OpenAlexW2055431114

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.